FDA approval of Keytruda sets positive regulatory precedent for CEL-SCI's Multikine in PD-L1 negative head and neck cancer

Bavarian Nordic sells US Priority Review Voucher for USD160m

Bavarian Nordic sells US Priority Review Voucher for USD160m

Clarity Pharmaceuticals agrees commercial manufacturing deal for Cu-64 SAR-bisPSMA with SpectronRx

Solve M.E. names Simmaron Research as ME/CFS Catalyst Award recipient

RemeGen's telitacicept (RC18) granted European Orphan Drug Designation for myasthenia gravis

CSL's ANDEMBRY (garadacimab-gxii) approved by US FDA for hereditary angioedema treatment

Celltrion's STEQEYMA (ustekinumab-stba) receives additional US FDA approval

ArkBio's NDA for Azstarys accepted and granted Chinese regulatory Priority Review

InspireMD secures CE Mark approval for CGuard Prime EPS under European MDR

FDA approves Merck's KEYTRUDA for perioperative use in PD-L1+ head and neck cancer

Alligator Bioscience gains FDA support for Phase 3 mitazalimab dose in pancreatic cancer

Sumitomo Pharma America's nuvisertib (TP-3654) receives US FDA Fast Track Designation for myelofibrosis treatment

Life Molecular Imaging's florbetaben (18F) granted orphan designation in Europe for Transthyretin (ATTR) Amyloidosis diagnosis

Specialised Therapeutics and Incyte include two additional therapies in expanded partnership